NORTH CHICAGO, Ill.,
May 20, 2021 /PRNewswire/
-- AbbVie (NYSE: ABBV) will participate in the UBS Global
Healthcare Virtual Conference on Tuesday,
May 25, 2021. Michael
Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and
chief financial officer, and Jeffrey R.
Stewart, executive vice president, commercial operations,
will present virtually at 11:00 a.m. Central
time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, women's health and
gastroenterology, in addition to products and services across its
Allergan Aesthetics portfolio. For more information about AbbVie,
please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original
content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-ubs-global-healthcare-virtual-conference-301295596.html
SOURCE AbbVie